COPD Assessment Test (CAT)
ورودیهای بالینی بیمار
حداقل ۰ — حداکثر ۵
حداقل ۰ — حداکثر ۵
حداقل ۰ — حداکثر ۵
حداقل ۰ — حداکثر ۵
حداقل ۰ — حداکثر ۵
حداقل ۰ — حداکثر ۵
حداقل ۰ — حداکثر ۵
حداقل ۰ — حداکثر ۵
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low impact0–10
- Medium impact11–20
- High impact21–30
- Very high impact31–40
The COPD Assessment Test (CAT) calculates assessing multiple aspects of COPD including respiratory symptoms, activity limitations, confidence, and sleep quality. Key inputs include cough. Scores guide determining appropriate admission level (floor versus ICU), tailoring antimicrobial therapy, and ventilatory support. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Quantifies the impact of COPD symptoms on patients' overall health and quality of life. The CAT is a patient-completed questionnaire that assesses multiple aspects of COPD including respiratory symptoms, activity limitations, confidence, and sleep quality.
Clinical Indication
The COPD Assessment Test (CAT) is indicated for bedside clinical practice to support Quantifies the impact of COPD symptoms on patients' overall health and quality of life. The CAT is a patient-completed questionnaire that assesses multiple aspects of COPD including respiratory symptoms, activity limitations, confidence, and sleep quality.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with community-acquired pneumonia, COPD exacerbations, acute asthma, pulmonary embolism, or acute respiratory distress. Clinical application is indicated across Respiratory care units, emergency pulmonary triage, sleep clinics, and medical floors.
Limitations & Contraindications
Peripheral pulse oximetry loses reliability in hypoperfusion, severe vasoconstriction, methemoglobinemia, or carboxyhemoglobinemia.
Clinical Pearls & Action Plan
Synchronous evaluation of arterial blood gas (PaO2/FiO2), mechanics of breathing, and clinical trajectory guides respiratory failure management. Guideline pearl: Should be repeated every 2-3 months to monitor progression and treatment response.
CAT Score = Sum of all 8 item scores (each scored 0-5)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| cough | integer | Yes | Frequency of coughing |
| phlegm | integer | Yes | Amount of phlegm (mucus) in chest |
| chest_tightness | integer | Yes | Feeling of chest tightness |
| breathlessness | integer | Yes | Breathlessness when walking up a hill or one flight of stairs |
| activities | integer | Yes | Limitation doing activities at home |
| confidence | integer | Yes | Confidence leaving home despite lung condition |
| sleep | integer | Yes | Sleep quality affected by lung condition |
| energy | integer | Yes | Energy level |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–10 | Low impact | Low COPD impact on health |
| 11–20 | Medium impact | Medium COPD impact on health |
| 21–30 | High impact | High COPD impact on health |
| 31–40 | Very high impact | Very high COPD impact on health |
Evidence-Based References (EBM)
- Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009 Sep;34(3):648-54. doi: 10.1183/09031936.00102509.DOI: 10.1183/09031936.00102509
- Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: 2023 Report.
- Gupta N, Pinto LM, Morogan A, Bourbeau J. The COPD assessment test: a systematic review. Eur Respir J. 2014 Oct;44(4):873-84. doi: 10.1183/09031936.00025214.DOI: 10.1183/09031936.00025214